Kathrin Zaugg
Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial.
Beck M, Li Q, Sumila M, Zaugg K, Guckenberger M, Ost P, Bosetti D, Reuter C, Gomez S, Khanfir K, Aebersold D, Ghadjar P, Schär C, Hayoz S, Papachristofilou A, Sassowsky M, Schär S, Mathier E, Halter M, Zwahlen D, Hölscher T, Arnold W, Polat B, Hildebrandt G, Müller A, Putora P, Pra A. Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial. Int J Radiat Oncol Biol Phys 2022; 113:80-91.
Jan 3, 2022Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial.
Jan 3, 2022Int J Radiat Oncol Biol Phys 2022; 113:80-91
Beck Marcus, Li Qiyu, Sumila Marcin, Zaugg Kathrin, Guckenberger Matthias, Ost Piet, Bosetti Davide G, Reuter Christiane, Gomez Silvia, Khanfir Kaouthar, Aebersold Daniel M, Ghadjar Pirus, Schär Corinne, Hayoz Stefanie, Papachristofilou Alexandros, Sassowsky Manfred, Schär Sämi, Mathier Etienne, Halter Matthias, Zwahlen Daniel R, Hölscher Tobias, Arnold Winfried, Polat Bülent, Hildebrandt Guido, Müller Arndt-Christian, Putora Paul Martin, Pra Alan Dal
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
Ghadjar P, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti D, Kaouthar K, Gomez S, Wust P, Thalmann G, Aebersold D, Sumila M, Schär C, Hayoz S, Bernhard J, Zwahlen D, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller A, Plasswilm L, Papachristofilou A, Swiss Group for Clinical Cancer Research (SAKK). Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial. Eur Urol 2021; 80:306-315.
Jun 14, 2021Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
Jun 14, 2021Eur Urol 2021; 80:306-315
Ghadjar Pirus, Zaugg Kathrin, Guckenberger Matthias, Ost Piet, Reuter Christiane, Bosetti Davide G, Kaouthar Khanfir, Gomez Silvia, Wust Peter, Thalmann George N, Aebersold Daniel M, Sumila Marcin, Schär Corinne, Hayoz Stefanie, Bernhard Jürg, Zwahlen Daniel R, Hölscher Tobias, Gut Philipp, Polat Bülent, Hildebrandt Guido, Müller Arndt-Christian, Plasswilm Ludwig, Papachristofilou Alexandros, Swiss Group for Clinical Cancer Research (SAKK)
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
Glatzer M, Kocher G, Kraxner P, Krueger T, Martucci F, Oehler C, Ozsahin M, Papachristofilou A, Wagnetz D, Zaugg K, Zwahlen D, Opitz I, Kestenholz P, Karenovics W, Leskow P, Caparrotti F, Elicin O, Furrer M, Gambazzi F, Dutly A, Gelpke H, Guckenberger M, Heuberger J, Inderbitzi R, Cafarotti S, Putora P. Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists. Transl Lung Cancer Res 2021; 10:1960-1968.
Apr 1, 2021Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
Apr 1, 2021Transl Lung Cancer Res 2021; 10:1960-1968
Glatzer Markus, Kocher Gregor Jan, Kraxner Peter, Krueger Thorsten, Martucci Francesco, Oehler Christoph, Ozsahin Mahmut, Papachristofilou Alexandros, Wagnetz Dirk, Zaugg Kathrin, Zwahlen Daniel, Opitz Isabelle, Kestenholz Peter, Karenovics Wolfram, Leskow Pawel, Caparrotti Francesca, Elicin Olgun, Furrer Markus, Gambazzi Franco, Dutly André, Gelpke Hans, Guckenberger Matthias, Heuberger Jürg, Inderbitzi Rolf, Cafarotti Stefano, Putora Paul Martin
A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives
Achard V, Matzinger O, Peguret N, Pesce G, Putora P, Reuter C, Richetti A, Vees H, Vrieling C, Zaugg K, Zimmermann F, Zwahlen D, Tsoutsou P, Kaouthar K, Huck C, Herrmann E, Aebersold D, Allal A, Andratschke N, Baumert B, Beer K, Betz M, Breuneval T, Bodis S, De Bari B, Förster R, Franzetti-Pellanda A, Guckenberger M, Zilli T. A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives. Radiother Oncol 2020; 150:1-3.
Jun 6, 2020A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives
Jun 6, 2020Radiother Oncol 2020; 150:1-3
Achard Vérane, Matzinger Oscar, Peguret Nicolas, Pesce Gianfranco, Putora Paul Martin, Reuter Christiane, Richetti Antonella, Vees Hansjörg, Vrieling Conny, Zaugg Kathrin, Zimmermann Frank, Zwahlen Daniel R, Tsoutsou Pelagia, Kaouthar Khanfir, Huck Constance, Herrmann Evelyn, Aebersold Daniel M, Allal Abdelkarim S, Andratschke Nicolaus, Baumert Brigitta G, Beer Karl T, Betz Michael, Breuneval Thomas, Bodis Stephan, De Bari Berardino, Förster Robert, Franzetti-Pellanda Alessandra, Guckenberger Matthias, Zilli Thomas
Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08)
von Moos R, Plasswilm L, Zwahlen D, Meier U, Yan P, Izzo P, Klingbiel D, Bärtschi D, Zaugg K, Saletti P, Rauch D, Koeberle D, Schacher S, Hayoz S, Winterhalder R, Roth A, Bodoky G, Samaras P, Berger M, Swiss Group for Clinical Cancer Research (SAKK). Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08). Eur J Cancer 2017; 89:82-89.
Dec 11, 2017Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08)
Dec 11, 2017Eur J Cancer 2017; 89:82-89
von Moos Roger, Plasswilm Ludwig, Zwahlen Daniel, Meier Urs R, Yan Pu, Izzo Paola, Klingbiel Dirk, Bärtschi Daniela, Zaugg Kathrin, Saletti Piercarlo, Rauch Daniel, Koeberle Dieter, Schacher Sabina, Hayoz Stefanie, Winterhalder Ralph C, Roth Arnaud, Bodoky György, Samaras Panagiotis, Berger Martin D, Swiss Group for Clinical Cancer Research (SAKK)
Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort
Cathomas R, De Santis M, Beyer J, Mayer F, Lorch A, Zaugg K, Seifert H, Shahin O, Rentsch C, Rothermundt C, Stenner F, Helbling D, Gillessen Sommer S. Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort. Swiss Med Wkly 2010; 140:356-69.
Jun 26, 2010Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort
Jun 26, 2010Swiss Med Wkly 2010; 140:356-69
Cathomas Richard, De Santis Maria, Beyer Jörg, Mayer Frank, Lorch Anja, Zaugg Kathrin, Seifert Hans-Helge, Shahin Osama, Rentsch Cyrill, Rothermundt Christian, Stenner Frank, Helbling Daniel, Gillessen Sommer Silke
Metastatic bone pain: treatment options with an emphasis on bisphosphonates
von Moos R, Strasser F, Gillessen Sommer S, Zaugg K. Metastatic bone pain: treatment options with an emphasis on bisphosphonates. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008; 16:1105-15.
Oct 1, 2008Metastatic bone pain: treatment options with an emphasis on bisphosphonates
Oct 1, 2008Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008; 16:1105-15
von Moos Roger, Strasser Florian, Gillessen Sommer Silke, Zaugg Kathrin